This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
5 Reasons That Make Albemarle (ALB) a Solid Choice Now
by Zacks Equity Research
Strong fundamentals and compelling growth prospects make Albemarle (ALB) an attractive choice for investment.
Zacks Industry Outlook Highlights: DowDuPont, Albemarle, Monsanto, Westlake Chemical and Kraton
by Zacks Equity Research
Zacks Industry Outlook Highlights: DowDuPont, Albemarle, Monsanto, Westlake Chemical and Kraton
Albemarle's (ALB) Q3 Earnings & Revenues Top, Ups View
by Zacks Equity Research
Strong results in the lithium business drove Albemarle's (ALB) Q3 results.
Can Albemarle (ALB) Beat Q3 Earnings on Lithium Strength?
by Zacks Equity Research
Strong momentum in Albemarle's (ALB) core Lithium and Advanced Materials unit is likely to continue in Q3.
Air Products (APD) Q4 Earnings & Revenues Top Estimates
by Zacks Equity Research
Strong segment performance contributed to Air Products' (APD) Q4 results.
BHP Billiton Reports Q1 Operational Results, Reaffirms View
by Zacks Equity Research
BHP Billiton's first-quarter fiscal 2018 iron-ore output dipped 3%. The company reaffirmed the productivity guidance for fiscal 2018.
Albemarle (ALB) Up 28% in 3 Months: What's Driving the Stock?
by Zacks Equity Research
Upbeat prospects for its lithium business are driving Albemarle's (ALB) shares.
Albemarle's Technology to Boost Lithium Production in Chile
by Zacks Equity Research
Albemarle (ALB) has asked Chile's Corfo to raise its lithium quota as the company's new technology is expected to allow it to sustainably increase total lithium production.
Albemarle Scales New 52-Week High: What's Driving it?
by Zacks Equity Research
Albemarle (ALB) is well placed to leverage strong expected growth in the battery-grade lithium market.
Why Is Albemarle (ALB) Down 3.5% Since the Last Earnings Report?
by Zacks Equity Research
Albemarle (ALB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Albemarle (ALB) Q2 Earnings Top Estimates, Sales Fall Short
by Zacks Equity Research
Strong results from the Lithium and Advanced Materials unit helped Albemarle (ALB) top earnings expectations in Q2.
Albemarle (ALB) Q2 Earnings Preview: What's in the Cards?
by Zacks Equity Research
Strength in lithium and bromine businesses is expected to support Albemarle's (ALB) Q2 results.
Domtar Corp (UFS) Q2 Earnings Beat Estimates, Stock Up 2.2%
by Zacks Equity Research
Strong productivity helps Domtar Corp. (UFS) report better-than-expected second-quarter 2017 adjusted earnings.
Cosan Limited's (CZZ) Growth Potential Solid, Runs Risks
by Zacks Equity Research
We issued an updated research report on Cosan Limited (CZZ) on Jul 17, 2017.
7 Reasons that Make Chemours (CC) a Solid Choice Right Now
by Zacks Equity Research
Strong fundamentals, upbeat outlook and compelling growth prospects make Chemours an attractive choice for investment.
Albemarle Touches New 52-Week High on Solid Prospects
by Zacks Equity Research
Shares of chemicals maker Albemarle (ALB) scaled a fresh 52-week high of $117.13 on July 12.
Dow Chemical to Sell Certain Corn Seed Assets for $1.1B
by Zacks Equity Research
Dow Chemical (DOW) has reached an agreement to divest a part of its corn seed business in Brazil to CITIC Agri Fund for $1.1 billion.
6 Reasons to Add Koppers (KOP) Stock to Your Portfolio
by Zacks Equity Research
Based on its compelling prospects, we believe Koppers (KOP) has plenty of upside potential.
PolyOne Buys Mesa, Expands Color & Additives Offerings
by Zacks Equity Research
PolyOne (POL) has purchased Mesa, a North American producer of color and additive materials and services.
6 Reasons that Make Albemarle (ALB) a Solid Choice Now
by Zacks Equity Research
Strong fundamentals and compelling growth prospects make Albemarle an attractive choice for investment.
Eastman Chemical vs Albemarle: Which Stock Is a Better Pick?
by Zacks Equity Research
Which Zacks Rank #2 stock is better placed in terms of fundamentals - Eastman Chemical (EMN) or Albemarle (ALB)?
Top Analyst Reports for Procter & Gamble, Verizon & Citigroup
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Procter & Gamble (PG), Verizon (VZ) and Citigroup (C).
Albemarle (ALB) Up 4.3% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Albemarle (ALB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Albemarle Hits New 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Shares of premier specialty chemical company, Albemarle (ALB), scaled a new 52-week high of $114.29 yesterday, before pulling back to close the day at $113.60.
Is Albemarle (ALB) Stock a Solid Choice Right Now?
by Zacks Equity Research
Albemarle (ALB) is seeing solid earnings estimate revision activity, and is a great company from a Zacks Industry Rank perspective.